Research programme: G protein-coupled receptor targeting antibodies - Tectonic Therapeutic
Latest Information Update: 29 Apr 2021
At a glance
- Originator Tectonic Therapeutic
- Class Antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified